Aquestive Therapeutics to Attend Key Investor Conferences
Aquestive Therapeutics Engages in Upcoming Investor Conferences
Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company dedicated to enhancing patient lives through innovative science and delivery technologies, is excited to announce its participation in two prominent investor conferences happening in September.
Conference Details
The management team at Aquestive Therapeutics will present at the following events:
- H.C. Wainwright 26th Annual Global Investor Conference: The presentation is scheduled for 8:30 am ET on a specified date and will include opportunities for investor meetings.
- Lake Street BIG8 Conference: This event will also provide an opportunity for the management to engage in investor meetings.
A Webcast Availability for Investors
For those unable to attend in person, a webcast of the H.C. Wainwright presentation will be accessible on the "Events and Presentation" page of the Investors section on the Company’s website. A replay will be available for a 30-day period following the live presentation, ensuring that interested parties have the chance to catch up on the insights shared during the event.
About Aquestive Therapeutics
Aquestive serves as a beacon in the pharmaceutical landscape, focusing on the development of orally administered products constructed to deliver complex molecules effectively. This innovation offers novel alternatives to traditional, invasive therapies that often prove inconvenient for patients.
Commercial Achievements
Aquestive has achieved notable success with five commercialized products, which are distributed through licensing agreements in various regions globally. The company remains the exclusive manufacturer of these products, underscoring its critical role in the supply chain.
Collaborative Efforts
To expand its innovative reach, Aquestive collaborates with other pharmaceutical entities to introduce new molecules into the market. Utilizing proprietary technologies, including the distinguished PharmFilm®, and leveraging extensive drug development capabilities, the Company consistently strives to enhance patient treatment options.
Future Product Developments
Aquestive is actively advancing a late-stage product candidate designed to treat severe allergic reactions, encompassing anaphylaxis. Additionally, the company is exploring an early-stage prodrug topical gel product candidate meant for various dermatological conditions. These efforts represent a commitment to diversifying treatment options across multiple health challenges.
Contact for Investor Inquiries
Interested parties seeking more information about the company or its upcoming presentations can reach out directly to their investor relations team. The contact is:
ICR Westwicke
Stephanie Carrington
Email: stephanie.carrington@westwicke.com
Phone: 646-277-1282
Frequently Asked Questions
What is the purpose of the upcoming investor conferences?
The conferences allow Aquestive Therapeutics to present their latest innovations and engage with investors to discuss company developments and future prospects.
Who is invited to attend the presentations?
Investors, analysts, and other stakeholders interested in learning more about Aquestive Therapeutics are encouraged to attend the presentations and meetings.
Will there be a recording of the presentations available?
Yes, webcasts of the presentations will be available on the Company’s website, and replays will be accessible for 30 days after the events.
What type of products is Aquestive developing?
Aquestive is focused on developing innovative orally administered medications that provide alternatives to traditional therapies, including products for allergic reactions and dermatological conditions.
How can investors contact Aquestive for further inquiries?
Investors can contact the investor relations team via email at stephanie.carrington@westwicke.com or call 646-277-1282.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/